- Home
- LENZ vs ARCT Comparison
LENZ vs ARCT Comparison
Compare LENZ & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LENZ
- ARCT
- Stock Information
- Founded
- LENZ 2019
- ARCT 2013
- Country
- LENZ United States
- ARCT United States
- Employees
- LENZ N/A
- ARCT N/A
- Industry
- LENZ Medicinal Chemicals and Botanical Products
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- LENZ Health Care
- ARCT Health Care
- Exchange
- LENZ Nasdaq
- ARCT Nasdaq
- Market Cap
- LENZ 664.5M
- ARCT 602.7M
- IPO Year
- LENZ 2021
- ARCT N/A
- Fundamental
- Price
- LENZ $24.67
- ARCT $19.79
- Analyst Decision
- LENZ Strong Buy
- ARCT Strong Buy
- Analyst Count
- LENZ 6
- ARCT 7
- Target Price
- LENZ $35.40
- ARCT $65.00
- AVG Volume (30 Days)
- LENZ 168.0K
- ARCT 336.8K
- Earning Date
- LENZ 08-14-2024
- ARCT 11-12-2024
- Dividend Yield
- LENZ N/A
- ARCT N/A
- EPS Growth
- LENZ N/A
- ARCT N/A
- EPS
- LENZ N/A
- ARCT N/A
- Revenue
- LENZ N/A
- ARCT $163,866,000.00
- Revenue This Year
- LENZ N/A
- ARCT $13.46
- Revenue Next Year
- LENZ N/A
- ARCT $5.17
- P/E Ratio
- LENZ N/A
- ARCT N/A
- Revenue Growth
- LENZ N/A
- ARCT N/A
- 52 Week Low
- LENZ $2.01
- ARCT $17.52
- 52 Week High
- LENZ $31.00
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- LENZ 50.64
- ARCT 39.34
- Support Level
- LENZ $25.13
- ARCT $19.44
- Resistance Level
- LENZ $31.00
- ARCT $21.20
- Average True Range (ATR)
- LENZ 2.09
- ARCT 1.20
- MACD
- LENZ 0.15
- ARCT -0.31
- Stochastic Oscillator
- LENZ 26.31
- ARCT 5.85
About LENZ LENZ Therapeutics Inc. Common Stock
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.